Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus?

Wozniak MA, Shipley SJ, Dobson CB, Parker SP, Scott FT, Leedham-Green M, Breuer J, Itzhaki RF.

Eur J Hum Genet. 2007 Jun;15(6):672-8. Epub 2007 Mar 14.

2.

Apolipoprotein E-epsilon 4 protects against severe liver disease caused by hepatitis C virus.

Wozniak MA, Itzhaki RF, Faragher EB, James MW, Ryder SD, Irving WL; Trent HCV Study Group.

Hepatology. 2002 Aug;36(2):456-63.

PMID:
12143056
3.

Management of herpes zoster (shingles) and postherpetic neuralgia.

Johnson RW, Whitton TL.

Expert Opin Pharmacother. 2004 Mar;5(3):551-9. Review.

PMID:
15013924
4.

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.

Pirttilä T, Haanpää M, Mehta PD, Lehtimäki T.

Acta Neurol Scand. 2000 Aug;102(2):94-8.

PMID:
10949525
5.

Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group.

Onozawa M, Hashino S, Haseyama Y, Hirayama Y, Iizuka S, Ishida T, Kaneda M, Kobayashi H, Kobayashi R, Koda K, Kurosawa M, Masauji N, Matsunaga T, Mori A, Mukai M, Nishio M, Noto S, Ota S, Sakai H, Suzuki N, Takahashi T, Tanaka J, Torimoto Y, Yoshida M, Fukuhara T.

Biol Blood Marrow Transplant. 2009 Jun;15(6):724-9. doi: 10.1016/j.bbmt.2009.03.003.

6.

Varicella virus-mononuclear cell interaction.

White TM, Gilden DH.

Adv Virus Res. 2003;62:1-17. Review.

PMID:
14719363
7.

Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.

Levin MJ, Schmader K.

Herpes. 2007 Sep;14 Suppl 2:45-7. Review.

PMID:
17939896
8.

Apolipoprotein E and herpes virus diseases: herpes simplex keratitis.

Lin WR, Tullo AB, Itzhaki RF.

Eur J Hum Genet. 1999 Apr;7(3):401-3.

9.

Does apolipoprotein E polymorphism influence susceptibility to malaria?

Wozniak MA, Faragher EB, Todd JA, Koram KA, Riley EM, Itzhaki RF.

J Med Genet. 2003 May;40(5):348-51.

10.

Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.

Meysman P, Ogunjimi B, Naulaerts S, Beutels P, Van Tendeloo V, Laukens K.

J Virol. 2015 Jan 15;89(2):962-9. doi: 10.1128/JVI.02500-14. Epub 2014 Oct 29.

11.

Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders.

Itzhaki RF, Wozniak MA.

Prog Lipid Res. 2006 Jan;45(1):73-90. Epub 2005 Dec 15. Review.

PMID:
16406033
12.

Herpes zoster virus vaccine.

Woolery WA.

Geriatrics. 2008 Oct;63(10):6-9. Review.

PMID:
18828650
13.

Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury.

Ost M, Nylén K, Csajbok L, Blennow K, Rosengren L, Nellgård B.

Acta Anaesthesiol Scand. 2008 Nov;52(10):1364-9. doi: 10.1111/j.1399-6576.2008.01675.x.

PMID:
19025529
14.

[Herpes zoster and postherpetic neuralgia - prevention by vaccination?].

Wutzler P.

Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S90-4. doi: 10.1055/s-0029-1220217. Epub 2009 Apr 7. German.

PMID:
19353479
15.

Predicting and preventing post-herpetic neuralgia: are current risk factors useful in clinical practice?

Coen PG, Scott F, Leedham-Green M, Nia T, Jamil A, Johnson RW, Breuer J.

Eur J Pain. 2006 Nov;10(8):695-700. Epub 2006 Jan 20.

PMID:
16427792
16.

Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.

Oxman MN.

J Am Osteopath Assoc. 2009 Jun;109(6 Suppl 2):S13-7. Review.

PMID:
19553630
17.

Assessment of transcriptomal analysis of Varicella-Zoster-virus gene expression in patients with and without post-herpetic neuralgia.

Ashrafi GH, Grinfeld E, Montague P, Forster T, Ross A, Ghazal P, Scott F, Breuer J, Goodwin R, Kennedy PG.

Virus Genes. 2010 Oct;41(2):192-201. doi: 10.1007/s11262-010-0515-2. Epub 2010 Jul 23.

PMID:
20652732
18.

Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.

Setzer M, Hermann E, Seifert V, Marquardt G.

Spine (Phila Pa 1976). 2008 Mar 1;33(5):497-502. doi: 10.1097/BRS.0b013e3181657cf7.

PMID:
18317192
19.

Prevention and management of trigeminal herpes zoster and postherpetic neuralgia.

Closmann JJ, Fielding CG, Pogrel MA.

Gen Dent. 2008 Sep-Oct;56(6):563-6; quiz 567-8, 591-2.

PMID:
18810918
20.

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.

Pellissier JM, Brisson M, Levin MJ.

Vaccine. 2007 Nov 28;25(49):8326-37. Epub 2007 Oct 17.

PMID:
17980938

Supplemental Content

Support Center